OTC : ADOCY

Adocia S.A.

$11.8 USD

$0 (0.0%)

Volume
200
Average Volume
112
Market Capitalization
$170.44M
P/E Ratio
-3.93
Dividend Yield
0.00%
Price Target
Year High
$11.80
Year Low
$11.80
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.19
Company Overview

OTC

Olivier Soula

Biotechnology

Healthcare

ADOCY

78

FR

USD

https://www.adocia.com

33 4 72 61 06 10

N/A

N/A

Liquidity Metrics

5.97

1.19

1.17

0.86

0.00

Sales & Valuation

$1.42M

51.68

50.10

-11.21

-0.35

Profitability

-$0.81

-$15.94M

-1124.81%

-1286.51%

-3796.57%

-58.31%

P/E Metrics

-3.93

0.07

0.07

Analyst Price Target & Rating

N/A

0/5

1 Analysts

%

Poll Results

About Adocia S.A. (OTC:ADOCY) Stock

Adocia S.A. is a clinical-stage biotechnology company dedicated to the research and development of novel formulations of established therapeutic proteins and peptides. Its primary focus is on addressing diabetes and various other metabolic disorders. Central to its work is the exclusive BioChaperone technological platform, engineered to significantly enhance the performance characteristics of therapeutic proteins. Its robust clinical pipeline features several advanced candidates: Insulin-based treatments: Including BioChaperone Lispro U100 and U200, which are ultra-fast-acting versions derived from rapid insulin lispro; BioChaperone Combo, combining long-acting insulin glargine with rapid-acting insulin lispro; and BioChaperone LisPram, which pairs prandial insulin with pramlintide. Hypogl ... ycemia treatment: BioChaperone Glucagon, an aqueous human glucagon solution specifically designed to manage severe low blood sugar episodes. Other: M1Pram, a derivative combining insulin glargine and pramlintide. The preclinical development programs further expand into bi-hormonal products such as BioChaperone AsPram, a combination of rapid insulin aspart and pramlintide, and BioChaperone Glargine Liraglutidea, a co-formulation of insulin glargine and a GLP-1 receptor analogue. Additionally, its preclinical portfolio targets obesity with multi-hormonal products like BioChaperone GluExe (glucagon and exenatide), PramExe (pramlintide and exenatide), and BioChaperone PramGluExe, a tripartite blend of pramlintide, glucagon, and exenatide. Adocia has forged a strategic partnership with Tonghua Dongbao Pharmaceutical Co., Ltd. for the development and market introduction of BioChaperone Lispro and BioChaperone Combo across China, other parts of Asia, and the Middle East. Established in 2005, the company maintains its headquarters in Lyon, France.

Frequently Asked Questions

What is the current Adocia S.A. (ADOCY) stock price?

Adocia S.A.(OTC:ADOCY) stock price is $11.8 in the last trading session. During the trading session, ADOCY stock reached the peak price of $11.8 while $11.8 was the lowest point it dropped to. The percentage change in ADOCY stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADOCY stock was $0.

ADOCY's industry and sector of operation?

The OTC listed ADOCY is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ADOCY?

David Duracher | Head of the Pharmaceutical Development & Physical Chemistry Departments and Project Manager
Gérard Soula | Co-Founder & Chairman of the Board
Grégory Meiffren | Head of the Biology Department & Project Manager
Jeremy Benattar | Marketing & Strategy Director
Olivier Soula | Co-Founder, Chief Executive Officer & Director

How many employees does ADOCY have?

Number of ADOCY employees currently stands at 78. ADOCY operates from 115 Avenue Lacassagne, Lyon, None 69003, FR.

Link for ADOCY official website?

Official Website of ADOCY is: https://www.adocia.com

How do I contact ADOCY?

ADOCY could be contacted at phone #33 4 72 61 06 10 and can also be accessed through its website. ADOCY operates from 115 Avenue Lacassagne, Lyon, None 69003, FR.

How many shares of ADOCY are traded daily?

The average number of ADOCY shares traded daily for last 3 months was 112.

What is the market cap of ADOCY currently?

The market value of ADOCY currently stands at $170.44M with its latest stock price at $11.8